Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Health Catalyst
HCAT
$139M
| $3.94M | ﹤0.01% |
315,300
+1,564
| +0.5% | +$18.6K |
|
2227
CALL
Delek US
DK
$4.01B
| $3.94M | ﹤0.01% |
+164,400
| New | +$3.73M |
|
2228
JD.com
JD
$39.2B
| $3.93M | ﹤0.01% |
115,124
+46,304
| +67% | +$1.68M |
|
2229
CALL
SLB Ltd
SLB
$79.8B
| $3.93M | ﹤0.01% |
+80,000
| New | +$3.81M |
|
2230
Smith & Nephew
SNN
$12.5B
| $3.93M | ﹤0.01% |
121,874
-21,876
| -15% | -$677K |
|
2231
AtriCure
ATRC
$2.25B
| $3.92M | ﹤0.01% |
79,514
-2,193
| -3% | -$101K |
|
2232
SentinelOne
S
$7.92B
| $3.92M | ﹤0.01% |
259,975
+236,152
| +991% | +$3.99M |
|
2233
CALL
TE Connectivity
TEL
$62.6B
| $3.92M | ﹤0.01% |
+28,000
| New | +$3.54M |
|
2234
Kanzhun
BZ
$6.93B
| $3.92M | ﹤0.01% |
260,551
-180,241
| -41% | -$3.02M |
|
2235
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.29B
| $3.92M | ﹤0.01% |
42,531
+12,190
| +40% | +$1.12M |
|
2236
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.4B
| $3.91M | ﹤0.01% |
80,075
-100,299
| -56% | -$4.91M |
|
2237
PUT
Fortis
FTS
$29B
| $3.91M | ﹤0.01% |
90,800
-20,000
| -18% | -$871K |
|
2238
Fidelity MSCI Health Care Index ETF
FHLC
$3.4B
| $3.91M | ﹤0.01% |
61,913
-26,855
| -30% | -$1.68M |
|
2239
Primerica
PRI
$9.65B
| $3.91M | ﹤0.01% |
19,749
+5,834
| +42% | +$1.07M |
|
2240
FlexShares STOXX US ESG Select Index Fund
ESG
$137M
| $3.9M | ﹤0.01% |
36,125
+11,090
| +44% | +$1.13M |
|
2241
CALL
Pembina Pipeline
PBA
$28.7B
| $3.9M | ﹤0.01% |
124,000
-215,400
| -63% | -$6.88M |
|
2242
Allegro MicroSystems
ALGM
$8.27B
| $3.9M | ﹤0.01% |
86,312
+69,726
| +420% | +$2.82M |
|
2243
Utz Brands
UTZ
$1.26B
| $3.89M | ﹤0.01% |
237,696
+12,062
| +5% | +$207K |
|
2244
iShares MSCI Switzerland ETF
EWL
$2.21B
| $3.88M | ﹤0.01% |
83,880
-211,600
| -72% | -$9.95M |
|
2245
Nuveen Municipal Value Fund
NUV
$1.9B
| $3.87M | ﹤0.01% |
445,326
+17,192
| +4% | +$151K |
|
2246
Leggett & Platt
LEG
$1.32B
| $3.87M | ﹤0.01% |
130,676
+3,892
| +3% | +$122K |
|
2247
ChargePoint
CHPT
$160M
| $3.87M | ﹤0.01% |
21,997
+1,992
| +10% | +$349K |
|
2248
Flowserve
FLS
$10.3B
| $3.85M | ﹤0.01% |
103,668
+1,098
| +1% | +$38.1K |
|
2249
FT Vest US Equity Buffer ETF October
FOCT
$1.2B
| $3.84M | ﹤0.01% |
101,809
-33,753
| -25% | -$1.21M |
|
|
ETNB
2250
DELISTED
89bio
ETNB
| $3.83M | ﹤0.01% |
202,158
+2,322
| +1% | +$40.8K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.